The benefits of using semaglutide GLP-1 for weight loss are significant
The company maintains a diversified portfolio across key therapeutic areas, including cardiovascular, central nervous system, pain management, and anti-infectives
Acute pancreatitis Lancet 2008;371:143-152 (en) Yadav D, Lowenfels AB
For GLP-receptor agonists, the rate ratio for pancreatitis relative to non-incretin comparator drugs or placebo was 1.342 (95% CI 0.643, 2.800, p = 0.434)
In those trials, semaglutide demonstrated average weight reductions of around 15% of body weight over 68 weeks when used alongside a reduced-calorie diet and increased physical activity
Brand Vitazan Professional Why choose Vitazan Professional The Vitazan label is available exclusively through health care professionals